Jordi Labs

Jordi Labs’ President, Dr. Mark Jordi, presents at BIOMEDevice Boston 2017

Extractable & Leachable Identification in Biopharmaceutical Manufacturing at BioMEDevice 2017

Jordi Labs proudly presented at the at BIOMEDevice Boston 2017, on May 3 & 4, 2017 at the Boston Convention & Exhibition Center in Boston, Massachusetts. Jordi Labs is a recognized leader in Extractables & Leachables (E&L) testing for biopharmaceuticals.

At the event, Dr. Mark Jordi educated the biopharmaceutical community on the importance of the analysis of E&L compounds from components employed in the storage or manufacture of biopharmaceuticals. Recent emphasis by the FDA as well as several high-profile incidents have raised awareness of the need for this information. The advent of single use bioprocess systems has introduced a new potential source for E&L’s as these systems are often comprised of polymeric materials.

As part of the discussion, Dr. Jordi presented an example analysis on a single use bioprocess system and use this case study to demonstrate an LC/MS and GC/MS software workflow for analysis of E&L’s. This workflow allows for the fast identification of E&L’s as well as rapid comparisons between samples.

About Jordi Labs

Founded in 1980, Jordi Labs provides the highest quality analytical services and polymer-based GPC columns in the industry. As a family company, we take pride in helping our customers overcome their analytical challenges by providing excellent products and personal assistance from our highly-trained staff. Whether you use our Resolve columns or our analytical services, we’re not finished until the job is done with integrity and excellence. That’s the Jordi Way.

Contact:

Patrick Burke, Vice President
Jordi Labs
508-966-8010
web@jordilabs.com

Exit mobile version